Trials / Completed
CompletedNCT00082082
A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
A Trial of Thymalfasin With Trans Arterial Chemo-Embolization (TACE) in the Treatment of Adult Patients With Unresectable Hepatocellular Carcinoma: A Phase II Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- SciClone Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this Phase II trial is to compare the efficacy and safety of 6 months of treatment with thymalfasin plus trans arterial chemoembolization (TACE) with TACE alone in adult patients with non-surgical hepatocellular carcinoma (HCC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Thymalfasin (thymosin alpha-1) | |
| PROCEDURE | Trans arterial chemoembolization (TACE) |
Timeline
- First posted
- 2004-04-30
- Last updated
- 2008-01-15
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00082082. Inclusion in this directory is not an endorsement.